#United States #New York #Securities Class Action #Faruqi & Faruqi #POMDOCTOR

Deadline Approaching for Pomdoctor Investors

Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively notifying Pomdoctor Limited shareholders of an impending deadline concerning a federal securities class action. Investors who acquired shares between October 9, 2025, and December 11, 2025, are invited to reach out to discuss their legal rights before the April 13, 2026 deadline.

Legal Investigation Commencement

In recent developments, the firm has begun its investigation into potential claims against Pomdoctor Limited following allegations of federal securities law violations. Reports indicate that the company and its executives may have engaged in activities that misled investors, including inaccuracies in public statements and the concealing of relevant risks.

Allegations Against Pomdoctor

The lawsuit asserts several significant claims, including:
1. Pomdoctor was involved in a fraudulent stock promotion scheme, utilizing misinformation spread through social media platforms and impersonated financial advisers.
2. Insiders reportedly used offshore accounts to systematically offload shares during a period of artificially inflated prices.
3. Public disclosures from Pomdoctor did not mention ongoing false rumors and manipulated trading activity that affected its stock value.
4. Consequently, positive statements regarding Pomdoctor's business operations were misleading, lacking a solid foundation.

On December 10, 2025, Pomdoctor shares closed at $0.50, but this price plummeted to approximately $0.38 in the following session, marking a 24% decrease. This drastic drop was influenced by an unstable trading atmosphere and rising investor skepticism regarding the company's financial health and stock value.

What It Means for Class Members

In this context, the lead plaintiff in the class action will be determined based on financial interest in the relief sought and their ability to represent the interests of the class adequately. However, any class member can submit a request to serve as the lead plaintiff through counsel of their choosing, or they can opt to remain uninvolved. Notably, the ability to receive a share of any recovery does not hinge on the decision to take on the role of lead plaintiff.

Faruqi & Faruqi, LLP encourages whistleblowers, former employees, and any individuals possessing knowledge of Pomdoctor's conduct to step forward. They are keen to gather information that could assist in this legal case. Interested parties can learn further details about the Pomdoctor class action by visiting the firm's website or by directly contacting partner Josh Wilson.

Contact Information

For a consultation, Pomdoctor investors can reach out to Josh Wilson at:

• - Phone: 877-247-4292 or 212-983-9330 (Extension 1310).
• - Additional information can also be found at Faruqi & Faruqi's Pomdoctor webpage.

Following these developments is crucial for all impacted stakeholders, ensuring they understand their rights and options as the deadline approaches.

In conclusion, Pomdoctor investors are strongly encouraged to be proactive in understanding their legal standing and to get in touch with Faruqi & Faruqi for assistance. Time is of the essence as the April 13, 2026 deadline nears, and acting now can make a significant difference in the pursuit of justice and recovery.